| SN | TITLE | RESEARCH AREAS | YEAR OF PUBLICATION | AUTHOR(S) |
|---|---|---|---|---|
| 1 | Individual and Sexual Network Predictors of HIV Incidence Among Men Who Have Sex With Men in Nigeria | HIV/AIDS | 01/03/2019 | |
| 2 | Compromised Growth Among HIV-exposed Uninfected Compared With Unexposed Children in Nigeria | MNCH | 01/03/2019 | |
| 3 | TLR10 senses HIV-1 proteins and significantly enhances HIV-1 infection | HIV/AIDS | 01/02/2019 | |
| 4 | Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identifiedRifampicin-resistant Tuberculosis in Post conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study | TB | 01/02/2019 | |
| 5 | Baseline PI susceptibility by HIV-1 Gag-protease phenotyping and subsequent virological suppression with PI-based second-line ART in Nigeria | HIV/AIDS | 01/02/2019 | |
| 6 | Correlates of reported modern contraceptive use among postpartum HIV-positive women in rural Nigeria: an analysis from the MoMent prospective cohort study | MNCH | 01/01/2019 | |
| 7 | Prevalence and incidence of genital warts and cervical Human Papillomavirus infections in Nigerian women | Cancer | 01/01/2019 | |
| 8 | Association between HIV-1 subtype and drug resistance in Nigerian infants | HIV/AIDS | 01/01/2019 | |
| 9 | “They do not see us as one of them”: a qualitative exploration of mentor mothers’ working relationships with healthcare workers in rural North-Central Nigeria | MNCH | 01/09/2018 | |
| 10 | Hepatitis C virus surveillance and identification of human pegivirus 2 in a large Cameroonian cohort | Other infections | 01/09/2018 | |
| 11 | Universal Target Capture of HIV Sequences From NGS Libraries | HIV/AIDS | 01/09/2018 | |
| 12 | Individual and Network Factors Associated With HIV Care Continuum Outcomes Among Nigerian MSM Accessing Health Care Services | HIV/AIDS | 01/09/2018 | |
| 13 | The role of connected diagnostics in strengthening regional, national and continental African disease surveillance | Research capacity building | 01/08/2018 | |
| 14 | Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria | HIV/AIDS | 01/08/2018 | |
| 15 | Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study | HIV/AIDS | 01/08/2018 | |
| 16 | Hand hygiene practices among nurses in health facility in a semi-urban setting | Other infections | 01/07/2018 | |
| 17 | Prevalence of anti-hepatitis C antibodies and its co-infection with HIV in rural Cameroon | Other infections | 01/07/2018 | |
| 18 | Secular trend in interobserver agreement of VIA diagnosis for cervical cancer screening in Nigeria | Cancer | 01/06/2018 | |
| 19 | Burden of depressive symptoms and non-alcohol substance abuse; and their association with alcohol use and partner violence: a cross-sectional study in four sub-Saharan Africa countries | NCDx | 01/06/2018 | |
| 20 | Health facility delivery in sub-Saharan Africa: successes, challenges, and implications for the 2030 development agenda | Research capacity building | 01/06/2018 | |
| 21 | Pediatric to adult healthcare transitioning for adolescents living with HIV in Nigeria: A national survey | MNCH | 01/06/2018 | |
| 22 | Age, HIV status, and research context determined attrition in a longitudinal cohort in Nigeria | HIV/AIDS | 01/04/2018 | |
| 23 | Generating evidence for health policy in challenging settings: lessons learned from four prevention of mother-to-child transmission of HIV implementation research studies in Nigeria | MNCH | 01/04/2018 | |
| 24 | Quality of life of patients treated for prostate cancer in a Nigerian hospital | Cancer | 01/03/2018 | |
| 25 | Achieving Viral Suppression in 90% of People Living with HIV on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities | HIV/AIDS | 01/03/2018 | |
| 26 | HIV status disclosure to male partners among rural Nigerian women along the prevention of mother-to-child transmission of HIV cascade: a mixed methods study | MNCH | 01/03/2018 | |
| 27 | Evaluation of Genxpert Real Time PCR POC in the Diagnosis of Multidrug Resistant TB Among Patients Attending NTBLTC Saye-Zaria Nigeria | TB | 01/03/2018 | |
| 28 | Correction to: Adolescent Coordinated Transition (ACT) to improve health outcomes among young people living with HIV in Nigeria: study protocol for a randomized controlled trial | Clinical trial | 01/02/2018 | |
| 29 | Consumption of processed food dietary patterns in four African populations | Other infections | 01/02/2018 | |
| 30 | Gaps and strategies in developing health research capacity: experience from the Nigeria Implementation Science Alliance | Research capacity building | 01/02/2018 | |
| 31 | In vitro Antimycobacterial Screening of Ficus sycomorus Extracts on Susceptible Strain of Mycobacterium tuberculosis | TB | 01/02/2018 | |
| 32 | Data resource profile: Cardiovascular H3Africa Innovation Resource (CHAIR) | Research capacity building | 01/12/2018 | |
| 33 | Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial | HIV/AIDS | 01/01/2018 | |
| 34 | Integrating community pharmacy into community based anti-retroviral therapy program: A pilot implementation in Abuja, Nigeria | HIV/AIDS | 01/01/2018 | |
| 35 | Cancers attributable to alcohol consumption in Nigeria | Cancer | 01/04/2017 | |
| 36 | Test–Retest Reliability of Self-Reported Sexual Behavior History in Urbanized Nigerian Women | Cancer | 01/04/2017 | |
| 37 | Cohort Profile: African Collaborative Center for Microbiome and Genomics Research’s (ACCME) Human Papillomavirus (HPV) and Cervical Cancer Study | Cancer | 01/04/2017 | |
| 38 | Persistent Low-Risk and High-Risk Human Papillomavirus Infections of the Uterine Cervix in HIV-Negative and HIV-Positive Women | Cancer | 01/04/2017 | |
| 39 | Integrated genomic and molecular characterization of cervical cancer | Cancer | 01/04/2017 | |
| 40 | Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria | CLinical trial | 01/04/2017 | |
| 41 | Multicenter Pivotal Clinical Trial of Urine Malaria Test for Rapid Diagnosis of Plasmodiumfalciparum Malaria | Clinical trial | 01/04/2017 | |
| 42 | Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations | HIV/AIDS | 01/04/2017 | |
| 43 | Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected in Nigeria | HIV/AIDS | 01/04/2017 | |
| 44 | Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics | HIV/AIDS | 01/04/2017 | |
| 45 | Psychological Stressors and Coping Strategies Used by Adolescents Living with and Not Living with Hiv Infection in Nigeria | HIV/AIDS | 01/04/2017 | |
| 46 | Mutational Correlates of Virological Failure in Individuals Receiving a WHO-RecommendedTenofovir-Containing First-Line Regimen: An International Collaboration | HIV/AIDS | 01/04/2017 | |
| 47 | Depression, suicidality, and alcohol use disorder among people living with HIV/AIDS in Nigeria | HIV/AIDS | 01/04/2017 | |
| 48 | Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon | HIV/AIDS | 01/04/2017 | |
| 49 | Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study | HIV/AIDS | 01/04/2017 | |
| 50 | Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations | HIV/AIDS | 01/04/2017 | |
| 51 | Modeling the Impact of Retention Interventions on Mother-to-Child Transmission of HIV: Results From INSPIRE Studies in Malawi, Nigeria, and Zimbabwe | MNCH | 01/04/2017 | |
| 52 | The Roles of Expert Mothers Engaged in Prevention of Mother-to-Child Transmission (PMTCT) Programs: A Commentary on the INSPIRE Studies in Malawi, Nigeria, and Zimbabwe | MNCH | 01/04/2017 | |
| 53 | The Impact of Structured Mentor Mother Programs on Presentation for Early Infant Diagnosis Testing in Rural North-Central Nigeria: A Prospective Paired Cohort Study | MNCH | 01/04/2017 | |
| 54 | The Impact of Structured Mentor Mother Programs on 6-Month Postpartum Retention and Viral Suppression among HIV-Positive Women in Rural Nigeria: A Prospective Paired Cohort Study | MNCH | 01/04/2017 | |
| 55 | Correlates of facility delivery for rural HIV-positive pregnant women enrolled in the MoMent Nigeria prospective cohort study | MNCH | 01/04/2017 | |
| 56 | Variation in neonatal mortality and its relation to country characteristics in sub-Saharan Africa: an ecological study | MNCH | 01/04/2017 | |
| 57 | A Mixed-Methods Study on Acceptability, Tolerability, and Substitution of Brown Rice for White Rice to Lower Blood Glucose Levels among Nigerian Adults | NCDx | 01/04/2017 | |
| 58 | Mycoplasma hominis and Mycoplasma genitaliumin the Vaginal Microbiota and Persistent High-Risk Human Papillomavirus Infection | Other infections | 01/04/2017 | |
| 59 | Sexual partner characteristics and incident rectal Neisseria gonorrhoeae and Chlamydia trachomatis infections among gay men and other men who have sex with men (MSM): a prospective cohort in Abuja and Lagos, Nigeria | Other infections | 01/04/2017 | |
| 60 | Status of Primary Health Workforce in a Nigerian State: Findings from Enrollment into a Digital Health Workforce Registry | Research capacity building | 01/04/2017 | |
| 61 | Lessons Learned from Biospecimen Shipping Among the Human Heredity and Health in Africa Biorepositories | Research capacity building | 01/04/2017 | |
| 62 | Selecting a Laboratory Information Management System for Biorepositories in Low- and Middle-Income Countries: The H3Africa Experience and Lessons Learned | Research capacity building | 01/04/2017 | |
| 63 | Improving Data Quality in a Resource Constraint Public Health Organization in Nigeria with Divide and Conquer and Lot Quality Assurance Sampling Approach | Research capacity building | 01/04/2017 | |
| 64 | Accessing Biospecimens from the H3Africa Consortium | Research capacity building | 01/04/2017 | |
| 65 | Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis. | TB | 01/04/2017 | |
| 66 | Diagnostic system strengthening for drug resistant tuberculosis in Nigeria: impact and challenges | TB | 01/04/2017 | |
| 67 | Delay in the Provision of Antiretroviral Therapy to HIV-infected TB Patients in Nigeria | TB | 01/04/2017 | |
| 68 | A Case Study of Multi Drug-Resistant Tuberculosis (MDR-TB), HIV and Diabetes Mellitus (Dm) Comorbidity: Triple Pathology; Challenges and Prospects | TB | 01/04/2017 | |
| 69 | Cognitive Function Among Antiretroviral Treatment–Naive Individuals Infected With Human Immunodeficiency Virus Type 1 Subtype G Versus CRF02_AG in Nigeria | HIV/AIDS | 01/12/2017 | |
| 70 | A Socio-Ecological Examination of Treatment Access, Uptake and Adherence Issues Encountered By HIV-Positive Women in Rural North-Central Nigeria | HIV/AIDS | 01/12/2017 | |
| 71 | ARCHITECT HIV Combo Ag/Ab and RealTime HIV-1 Assays Detect Diverse HIV Strains in ClinicalSpecimens | HIV/AIDS | 01/12/2017 | |
| 72 | Cardiovascular Risk Factors in South-Western Nigeria: A WHO StepWise Approach | Other infections | 01/12/2017 | |
| 73 | ACCME Research Group as part of the H3Africa Consortium; Cohort Profile: African Collaborative Center for Microbiome and Genomics Research’s (ACCME) Human Papillomavirus (HPV) and Cervical Cancer Study. | Genetics and Genomics | 13/12/2024 | |
| 74 | A Decade of Monitoring HIV Epidemics in Nigeria: Positioning for Post-2015 Agenda. | HIV/AIDS | 13/12/2024 | |
| 75 | Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations. | HIV/AIDS | 13/12/2024 | |
| 76 | Depression, suicidality, and alcohol use disorder among people living with HIV/AIDS in Nigeria | HIV/AIDS | 13/12/2024 | |
| 77 | Immunological and clinical assessment of adult HIV patients following switch to second-line antiretroviral regimen in a large HIV Program in North-central Nigeria. | HIV/AIDS | 13/12/2024 | |
| 78 | Modeling the Impact of Retention Interventions onMother-to-Child Transmission of HIV: Results From INSPIRE Studies in Malawi,Nigeria, and Zimbabwe. | MNCH | 13/12/2024 | |
| 79 | The Roles of Expert Mothers Engaged in Prevention of Mother-to-Child Transmission (PMTCT) Programs: A Commentary on the INSPIRE Studies in Malawi, Nigeria, and Zimbabwe | MNCH | 13/12/2024 | |
| 80 | Test-Retest Reliability of Self-Reported Sexual Behavior History in Urbanized Nigerian Women. | Research capacity building | 13/12/2024 | |
| 81 | Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria. | Cancer | 13/12/2024 | |
| 82 | The Burden of Human Papilloma Virus Associated Cancers in Nigeria. | Cancer | 13/12/2024 | |
| 83 | Cancers Attributable to Infectious Agents in Nigeria: 2012-2014 | Cancer | 13/12/2024 | |
| 84 | Delays in breast cancer presentation and diagnosis in Nigeria. | Cancer | 13/12/2024 | |
| 85 | Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis. | Cancer | 13/12/2024 | |
| 86 | Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan Africa. | Cancer | 13/12/2024 | |
| 87 | Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women. | Cancer | 13/12/2024 | |
| 88 | Qualitative study of barriers to cervical cancer screening among Nigerian women. | Cancer | 13/12/2024 | |
| 89 | Psychological Stressors and Coping Strategies Used by Adolescents Living with and Not Living with HIV Infection in Nigeria. | HIV/AIDS | 13/12/2024 | |
| 90 | Seeking wider access to HIV testing for adolescents in sub-Saharan Africa. | HIV/AIDS | 13/12/2024 | |
| 91 | Development of a prospective cohort of HIV Exposed Sero-Negative (HESN) individuals in Jos Nigeria. | HIV/AIDS | 13/12/2024 | |
| 92 | Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial | HIV/AIDS | 13/12/2024 | |
| 93 | HIV associated high-risk HPV infection among Nigerian women | HIV/AIDS | 13/12/2024 | |
| 94 | Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria. | HIV/AIDS | 13/12/2024 | |
| 95 | Implementing Quality Assurance in HIV testing and POC in Nigeria: In-country Experience. | HIV/AIDS | 13/12/2024 | |
| 96 | Multicenter Pivotal Clinical Trial of Urine Malaria Test for Rapid Diagnosis of Plasmodium falciparum Malaria | Malaria | 13/12/2024 | |
| 97 | Linkage to Care, Early Infant Diagnosis, and Perinatal Transmission Among Infants Born to HIV-Infected Nigerian Mothers: Evidence From the Healthy Beginning Initiative. | MNCH | 13/12/2024 | |
| 98 | Identifying and Prioritizing Implementation Barriers, Gaps, and Strategies Through the Nigeria Implementation Science Alliance: Getting to Zero in the Prevention of Mother-to-Child Transmission of HIV. | MNCH | 13/12/2024 | |
| 99 | Evaluating Religious Influences on the Utilization of Maternal Health Services among Muslim and Christian Women in North-Central Nigeria | MNCH | 13/12/2024 | |
| 100 | Building Sustainable Local Capacity for Global Health Research in West Africa. | Research capacity building | 13/12/2024 | |
| 101 | Recurrence of cervical intraepithelial lesions after thermo-coagulation in HIV-positive and HIV-negative Nigerian women. | Cancer | 13/12/2024 | |
| 102 | Developing National Cancer Registration in Developing Countries - Case Study of the Nigerian National System of Cancer Registries. | Cancer | 13/12/2024 | |
| 103 | Comparability, diagnostic validity and completeness of Nigerian cancer registries. | Cancer | 13/12/2024 | |
| 104 | Influence of Spirituality and Modesty on Acceptance of Self-Sampling for Cervical Cancer Screening. | Cancer | 13/12/2024 | |
| 105 | Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria | HIV/AIDS | 13/12/2024 | |
| 106 | Partner HIV serostatus disclosure and determinants of serodiscordance among prevention of mother to child transmission clients in Nigeria. | HIV/AIDS | 13/12/2024 | |
| 107 | Can oral fluid testing be used to replace blood-based HIV rapid testing to scale up access to diagnosis and treatment in Cameroon? | HIV/AIDS | 13/12/2024 | |
| 108 | Baseline Clinical Profile of a ‘normal population’ of HIV Exposed Sero-Negative (HESN) partners may Impact HIV Biomedical Prevention Studies Negatively. | HIV/AIDS | 13/12/2024 | |
| 109 | Uptake of Treatment as Prevention for HIV and Continuum of Care among HIV-positive Men who have Sex with Men in Nigeria | HIV/AIDS | 13/12/2024 | |
| 110 | Adherence to anti-retroviral therapy in North Central Nigeria. | HIV/AIDS | 13/12/2024 | |
| 111 | Improved Performance of COBAS AmpliPrep/COBAS TaqMan Version 2.0 Assay Over Amplicor Monitor Version 1.5 in the Quantification of HIV1 RNA Viral Load in Abuja, Nigeria. | HIV/AIDS | 13/12/2024 | |
| 112 | Current Trends in the detection of Acute HIV Infection among Blood Donors: Reliability of Pooled Nucleic Acid Amplification Technology and the Need for Population Specific Algorithms | HIV/AIDS | 13/12/2024 | |
| 113 | Analysis of Reported Cases of Lassa Fever in Plateau State and the Need for Strategic Action Plan | Other infections | 13/12/2024 | |
| 114 | Update on HIV-1 Acquired and Transmitted Drug Resistance in Africa | Pharmacoepid | 13/12/2024 | |
| 115 | Doing No Harm? Adverse Events in a Nation-Wide Cohort of Patients with Multidrug-Resistant Tuberculosis in Nigeria. | Pharmacoepid | 13/12/2024 | |
| 116 | Procurement and Supply Management System for MDR-TB in Nigeria: Are the Early Warning Targets for Drug Stock Outs and Over Stock of Drugs Being Achieved? | TB | 13/12/2024 | |
| 117 | Performance of Genotype MTBDRplus in the Detection of Resistance to Rifampicin and Isoniazid Among Clinical Mycobacteria Isolates in Ilorin, Nigeria. | TB | 13/12/2024 | |
| 118 | Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons | TB | 13/12/2024 | |
| 119 | Long-Term Outcome of Second-Line Antiretroviral Therapy in Resource-Limited Settings | HIV/AIDS | 13/12/2024 | |
| 120 | Comprehensive reference ranges for hematology and clinical chemistry laboratory parametersderived from normal Nigerian adults | HIV/AIDS | 13/12/2024 | |
| 121 | Comprehensive Reference Ranges for Clinical Hematology and Chemistry Laboratory Parameters Derived from Normal Nigerian adults. | HIV/AIDS | 13/12/2024 | |
| 122 | The impact of mentor mother programs on PMTCT service uptake and retention-in-care at primary health care facilities in Nigeria: a prospective cohort study. | MNCH | 13/12/2024 | |
| 123 | The Impact of Structured Mentor Mother Programs on 6-Month Postpartum Retention and Viral Suppression among HIV-Positive Women in Rural Nigeria: A Prospective Paired Cohort Study. | MNCH | 13/12/2024 | |
| 124 | The Impact of Structured Mentor Mother Programs on Presentation for Early Infant Diagnosis Testing in Rural North-Central Nigeria: A Prospective Paired Cohort Study. | MNCH | 13/12/2024 | |
| 125 | Obesity epidemic has emerged among Nigerians | NCDx | 13/12/2024 | |
| 126 | Consensus standards for introductory e-learning courses in human participants research ethics | Reaserch capacity building | 13/12/2024 | |
| 127 | Optimizing Mycobacterium tuberculosis detection in resource limited settings. | TB | 13/12/2024 | |
| 128 | RPS19 and TYMS SNPs and Prevalent High Risk Human Papilloma Virus Infection in Nigerian women | Cancer | 13/12/2024 | |
| 129 | Discordant couples cohort is still relevant for HIV vaccine studies despite low transmission rates: Canadian-Nigerian experience | HIV/AIDS | 13/12/2024 | |
| 130 | Preparing for HIV Vaccine Trials in Nigeria: Building the Capacity of the Community and National Coordinating, Regulatory and Ethical Bodies. | HIV/AIDS | 13/12/2024 | |
| 131 | Mycobacterial etiology of pulmonary tuberculosis and association with HIV infection and multidrub resistance in northern Nigeria. | TB | 13/12/2024 | |
| 132 | The role of hospital-based cancer registries in low and middle income countries-The Nigerian Case Study. | Cancer | 13/12/2024 | |
| 133 | Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer | Cancer | 13/12/2024 | |
| 134 | Knowledge, attitudes and practices of AIDS associated malignancies among people living with HIV in Nigeria. | Cancer | 13/12/2024 | |
| 135 | Digital cervicography and cold coagulation for cervical cancer screening in Nigeria. | Cancer | 13/12/2024 | |
| 136 | An Idea Whose Time Has Come? An African Foresight Observatory on Genomics Medicine and Data-Intensive Global Science | Genetics and Genomics | 13/12/2024 | |
| 137 | Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria. | HIV/AIDS | 13/12/2024 | |
| 138 | Demographic predictors of HIV serostatus among HIV counseling and testing clients in rural Nigeria. | HIV/AIDS | 13/12/2024 | |
| 139 | Low Lymphocyte Count In HIV- Pregnancy And Strategies For Treatment. In Scientific Basis of Healthcare: AIDS & Pregnancy. | HIV/AIDS | 13/12/2024 | |
| 140 | Confirmation of putative HIV-1 group P in Cameroon | HIV/AIDS | 13/12/2024 | |
| 141 | High Frequency of HIV-1 Dual Infections in Cameroon, West Central Africa | HIV/AIDS | 13/12/2024 | |
| 142 | The outcome of prevention of mother to child transmission (PMTCT) of HIV infection programme in Nnewi, southeast Nigeria. | MNCH | 13/12/2024 | |
| 143 | Non-communicable diseases in sub-Saharan Africa: what we know now | NCDx | 13/12/2024 | |
| 144 | Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors. | HIV/AIDS | 13/12/2024 | |
| 145 | Medical Ethics Education: A Survey of Opinion of Medical Students in a Nigerian University | Research capacity building | 13/12/2024 | |
| 146 | Challenges in treating malignancies in HIV in Nigeria | Cancer | 13/12/2024 | |
| 147 | Evaluation of the Detection Threshold of Three lmmunochromotographic Rapid Diagnostic Test (ROT) Kits for Falciparum Malaria Using Titration Technique | Malaria | 13/12/2024 |
PUBLICATIONS
We are open:
Mondays – Thursdays: 8am – 5pm
Fridays: 8am – 2pm
Extra Links
- IHVN Website
- IHAB Website
- Inform Africa
- CAWISA
- TRiAD
- Careers
Contact Us
- Tower A, IHVN Campus, Plot 62, Cadastral Zone COO, Behind National Judicial Institute, off Jabi Airport Road, FCT-Abuja.
- 234 (908) 6592530, +234 (908) 6592531
- irceinquiries@ihvnigeria.org
Copyright © 2025 IHVN-IRCE | All rights reserved.